Literature DB >> 24166197

MicroRNA-205 suppresses the oral carcinoma oncogenic activity via down-regulation of Axin-2 in KB human oral cancer cell.

Jae-Sung Kim1, Sun-Young Park, Seul Ah Lee, Min-Gyeong Park, Sun-Kyoung Yu, Myoung-Hwa Lee, Mi-Ra Park, Su-Gwan Kim, Ji-Su Oh, Sook-Young Lee, Chun Sung Kim, Heung-Joong Kim, Hong Sung Chun, Jin-Soo Kim, Sung-Min Moon, Do Kyung Kim.   

Abstract

MicroRNA (miRNA) is a small noncoding RNA molecule, 19-25 nucleotides in length, which regulates several pathways including cell development, cell proliferation, carcinogenesis, apoptosis, etc. In this study, the over-expression of microRNA-205 (miR-205) increased the number of apoptotic cells by at least 4 times compared to the control. In addition, over-expressed miRNA in KB oral cancer cells triggered apoptosis via the caspase cascade, including the cleavage of caspase-9, caspase-7, caspase-3, and PARP. Flow cytometry showed that apoptotic cell death was increased significantly by 35.33% in KB oral cancer cells with over-expressed miR-205 compared to the control. The microarray data showed that axis inhibitor protein 2 (Axin2) was down-regulated in KB oral cancer cells transfected with miR-205. In addition, Axin2 was down-regulated by approximately 50% by over-expressed miR-205 at both the mRNA and protein levels. Interestingly, Axin2 was up-regulated in KB oral cancer compared to human normal oral keratinocytes. Furthermore, the cell cytotoxicity and apoptotic population of KB oral cancer cells were increased significantly after Axin2 siRNA transfection. These results suggest that Axin2 is might be as potential oncogene in KB oral cancer cells. The luciferase assay showed that over-expressed miR-205 in KB oral cancer cells suppressed AXIN2 expression through an interaction with its own binding site at AXIN2 3'UTR (64-92). These results suggest that miR-205 is a novel anti-oncogenic miRNA in KB oral cancer cells, and may have potential applications in oral cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24166197     DOI: 10.1007/s11010-013-1872-7

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  26 in total

1.  Wnt-1 signaling inhibits human umbilical vein endothelial cell proliferation and alters cell morphology.

Authors:  Ching-wen Cheng; Stephen K Smith; D Stephen Charnock-Jones
Journal:  Exp Cell Res       Date:  2003-12-10       Impact factor: 3.905

2.  Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway.

Authors:  Eek-hoon Jho; Tong Zhang; Claire Domon; Choun-Ki Joo; Jean-Noel Freund; Frank Costantini
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

3.  Wnt/beta-catenin signaling induces proliferation, survival and interleukin-8 in human endothelial cells.

Authors:  T Néstor H Masckauchán; Carrie J Shawber; Yasuhiro Funahashi; Chi-Ming Li; Jan Kitajewski
Journal:  Angiogenesis       Date:  2005       Impact factor: 9.596

4.  MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer.

Authors:  Shahana Majid; Altaf A Dar; Sharanjot Saini; Soichiro Yamamura; Hiroshi Hirata; Yuichiro Tanaka; Guoren Deng; Rajvir Dahiya
Journal:  Cancer       Date:  2010-08-24       Impact factor: 6.860

5.  Chemically modified synthetic microRNA-205 inhibits the growth of melanoma cells in vitro and in vivo.

Authors:  Shunsuke Noguchi; Junya Iwasaki; Minami Kumazaki; Takashi Mori; Kohji Maruo; Hiroki Sakai; Nami Yamada; Kazuyuki Shimada; Tomoki Naoe; Yukio Kitade; Yukihiro Akao
Journal:  Mol Ther       Date:  2013-04-30       Impact factor: 11.454

6.  Loss of microRNA-205 expression is associated with melanoma progression.

Authors:  Shujing Liu; Michael T Tetzlaff; Aihua Liu; Bernadette Liegl-Atzwanger; Jun Guo; Xiaowei Xu
Journal:  Lab Invest       Date:  2012-04-23       Impact factor: 5.662

7.  microRNA-205 regulates HER3 in human breast cancer.

Authors:  Marilena V Iorio; Patrizia Casalini; Claudia Piovan; Gianpiero Di Leva; Andrea Merlo; Tiziana Triulzi; Sylvie Ménard; Carlo M Croce; Elda Tagliabue
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

8.  MicroRNA-205 directly regulates the tumor suppressor, interleukin-24, in human KB oral cancer cells.

Authors:  Jae-Sung Kim; Sun-Kyoung Yu; Myoung-Hwa Lee; Min-Gyeong Park; Euteum Park; Su-Gwan Kim; Sook-Young Lee; Chun Sung Kim; Heung-Joong Kim; Hong Sung Chun; Sang-Woo Chun; Do Kyung Kim
Journal:  Mol Cells       Date:  2012-12-03       Impact factor: 5.034

9.  Frameshift mutations of Wnt pathway genes AXIN2 and TCF7L2 in gastric carcinomas with high microsatellite instability.

Authors:  Min Sung Kim; Sung Soo Kim; Chang Hyeok Ahn; Nam Jin Yoo; Sug Hyung Lee
Journal:  Hum Pathol       Date:  2008-08-27       Impact factor: 3.466

10.  Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer.

Authors:  Paola Tucci; Massimiliano Agostini; Francesca Grespi; Elke K Markert; Alessandro Terrinoni; Karen H Vousden; Patricia A J Muller; Volker Dötsch; Sebastian Kehrloesser; Berna S Sayan; Giuseppe Giaccone; Scott W Lowe; Nozomi Takahashi; Peter Vandenabeele; Richard A Knight; Arnold J Levine; Gerry Melino
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

View more
  12 in total

Review 1.  The roles of AXIN2 in tumorigenesis and epigenetic regulation.

Authors:  Shuang Li; Chunpeng Wang; Xiaodong Liu; Shucheng Hua; Xin Liu
Journal:  Fam Cancer       Date:  2015-06       Impact factor: 2.375

Review 2.  MicroRNAs as effective surrogate biomarkers for early diagnosis of oral cancer.

Authors:  Min Cao; Lijuan Zheng; Jianzhou Liu; Thomas Dobleman; Shen Hu; Vay Liang W Go; Ge Gao; Gary Guishan Xiao
Journal:  Clin Oral Investig       Date:  2018-01-03       Impact factor: 3.573

3.  MicroRNA-205 functions as a tumor suppressor in colorectal cancer by targeting cAMP responsive element binding protein 1 (CREB1).

Authors:  Peng Li; Wan-Jiang Xue; Ying Feng; Qin-Sheng Mao
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

4.  MicroRNA-205 is downregulated in hepatocellular carcinoma and inhibits cell growth and metastasis via directly targeting vascular endothelial growth factor A.

Authors:  Xuya Zhao; Shi Zhou; Dazhi Wang; Wei He; Junxiang Li; Shuai Zhang
Journal:  Oncol Lett       Date:  2018-06-08       Impact factor: 2.967

Review 5.  A Looking-Glass of Non-coding RNAs in oral cancer.

Authors:  Alexandra Iulia Irimie; Cornelia Braicu; Laura Sonea; Alina Andreea Zimta; Roxana Cojocneanu-Petric; Konstantin Tonchev; Nikolay Mehterov; Diana Diudea; Smaranda Buduru; Ioana Berindan-Neagoe
Journal:  Int J Mol Sci       Date:  2017-12-05       Impact factor: 5.923

Review 6.  Axin Family of Scaffolding Proteins in Development: Lessons from C. elegans.

Authors:  Avijit Mallick; Shane K B Taylor; Ayush Ranawade; Bhagwati P Gupta
Journal:  J Dev Biol       Date:  2019-10-15

Review 7.  MicroRNAs as Important Players and Biomarkers in Oral Carcinogenesis.

Authors:  Anjie Min; Chao Zhu; Shuping Peng; Saroj Rajthala; Daniela Elena Costea; Dipak Sapkota
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411

Review 8.  MicroRNAs: novel players in cancer diagnosis and therapies.

Authors:  Aaron L Oom; Brock A Humphries; Chengfeng Yang
Journal:  Biomed Res Int       Date:  2014-07-02       Impact factor: 3.411

9.  microRNA-544 promoted human osteosarcoma cell proliferation by downregulating AXIN2 expression.

Authors:  Ming Chen; Yong-Yi Liu; Min-Qing Zheng; Xin-Liang Wang; Xing-Hua Gao; Lin Chen; Guang-Ming Zhang
Journal:  Oncol Lett       Date:  2018-03-08       Impact factor: 2.967

10.  Tumor-suppressive roles of ΔNp63β-miR-205 axis in epithelial-mesenchymal transition of oral squamous cell carcinoma via targeting ZEB1 and ZEB2.

Authors:  Yuma Hashiguchi; Shintaro Kawano; Yuichi Goto; Kaori Yasuda; Naoki Kaneko; Taiki Sakamoto; Ryota Matsubara; Teppei Jinno; Yasuyuki Maruse; Hideaki Tanaka; Masahiko Morioka; Taichi Hattori; Shoichi Tanaka; Tamotsu Kiyoshima; Seiji Nakamura
Journal:  J Cell Physiol       Date:  2018-05-10       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.